An arrhythmic variant of the manifestation of paraneoplastic Loeffler endomyocarditis. Clinical case

Abstract

A clinical case of chronic undulating course of parneoplastic Loeffler endomyocarditis, the leading manifestations of which were ventricular arrhythmias, is presented. The paper demonstrates the complexity of early diagnosis of a rare pathology in a polymorbid patient and attempts to identify the "keys" to the correct diagnostic and therapeutic tactics for managing such patients.

Keywords

hypereosinophilic syndrome / hypereosinophilia / reciprocal ventricular tachycardia / Loeffler endocarditis / eosinophilic myocarditis

References

[1] Hoffman R, Edward J, Benz E, et al. Hematology, basic principles and practice. 8th edition. Elsevier; 2022;1243–1257. doi: 9780323733892

[2] Hoffman R., Edward J., Benz E., et al. Hematology, basic principles and practice. 8th edition. Elsevier, 2022. P. 1243–1257. doi: 9780323733892

[3] Hoffman R, Edward J, Benz E, et al. Hematology, basic principles and practice. 8th edition. Elsevier; 2022;1243–1257. doi: 9780323733892

[4] Loeffler W. Scientific raisins from 125 years SMW (Swiss Medical Weekly). 2nd international medical week dedicated in Switzerland. Luzern, 31 August — 5 September 1936. Fibroplastic parietal endocarditis with eosinophilia. An unusual disease. 1936. Schweizerische Medizinische Wochenschrift. 1995;125:1837–1840. (In German.)

[5] Löffler W. Wissenschaftliche Rosinen aus 125 Jahren SMW. Der II. Internationalen Medizinischen Woche in der Schweiz gewidmet. Luzern, 31. August-5. September 1936. Endocarditis parietalis fibroplastica mit Bluteosinophilie. Ein eigenartiges Krankheitsbild. 1936 // Schweizerische Medizinische Wochenschrift. 1995. Vol. 125. S. 1837–1840.

[6] Loeffler W. Scientific raisins from 125 years SMW (Swiss Medical Weekly). 2nd international medical week dedicated in Switzerland. Luzern, 31 August — 5 September 1936. Fibroplastic parietal endocarditis with eosinophilia. An unusual disease. 1936. Schweizerische Medizinische Wochenschrift. 1995;125:1837–1840. (In German.)

[7] Chao BH, Cline-Parhamovich K, Grizzard JD. Fatal Loeffler’s endocarditis due to hypereosinophilic syndrome. Am J Hematol. 2007;82(10):920–923. doi: 10.1002/ajh.20933

[8] Chao B.H., Cline-Parhamovich K., Grizzard J.D. Fatal Loeffler’s endocarditis due to hypereosinophilic syndrome // Am J Hematol. 2007. Vol. 82, N 10. P. 920–923. doi: 10.1002/ajh.20933

[9] Chao BH, Cline-Parhamovich K, Grizzard JD. Fatal Loeffler’s endocarditis due to hypereosinophilic syndrome. Am J Hematol. 2007;82(10):920–923. doi: 10.1002/ajh.20933

[10] Crane MM, Chang CM, Kobayashi MG, Weller PF. Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol. 2010;126(1):179–181. doi: 10.1016/j.jaci.2010.03.035

[11] Crane M.M., Chang C.M., Kobayashi M.G., Weller P.F. Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence // J Allergy Clin Immunol. 2010. Vol. 126, N 1. P. 179–181. doi: 10.1016/j.jaci.2010.03.035

[12] Crane MM, Chang CM, Kobayashi MG, Weller PF. Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol. 2010;126(1):179–181. doi: 10.1016/j.jaci.2010.03.035

[13] Mubarik A, Iqbal AM. Loeffler Endocarditis. [Updated 2024 Jan 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2024 Jan. — [cited 2024 Sept 18] Available from: https://www.statpearls.com/point-of-care/21092

[14] Mubarik A., Iqbal A.M. Loeffler Endocarditis. [Updated 2024 Jan 7]. В кн.: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2024 Jan. Режим доступа: https://www.statpearls.com/point-of-care/21092 Дата обращения: 18.09.2024.

[15] Mubarik A, Iqbal AM. Loeffler Endocarditis. [Updated 2024 Jan 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2024 Jan. — [cited 2024 Sept 18] Available from: https://www.statpearls.com/point-of-care/21092

[16] Ogbogu PU, Rosing DR, Horne MK 3rd. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27(3):457–475. doi: 10.1016/j.iac.2007.07.001

[17] Ogbogu P.U., Rosing D.R., Horne M.K. 3rd. Cardiovascular manifestations of hypereosinophilic syndromes // Immunol Allergy Clin North Am. 2007. Vol. 27, N 3. P. 457–475. doi: 10.1016/j.iac.2007.07.001

[18] Ogbogu PU, Rosing DR, Horne MK 3rd. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27(3):457–475. doi: 10.1016/j.iac.2007.07.001

[19] Otto KM. Clinical echocardiography: a practical guide / transl. from English; ed. by Sandrikov VA; edited by Galagudza MM, Domnitskaya TM, Zelenikin MM, et al. Moscow: Logosphere; 2019. P. 688–690. EDN: BUAHUQ

[20] Отто К.М. Клиническая эхокардиография: практическое руководство / пер. с англ.; под ред. М.М. Галагудзы, Т.М. Домницкой, М.М. Зеленикина, и др. Москва: Логосфера, 2019. C. 688–690. EDN: BUAHUQ

[21] Otto KM. Clinical echocardiography: a practical guide / transl. from English; ed. by Sandrikov VA; edited by Galagudza MM, Domnitskaya TM, Zelenikin MM, et al. Moscow: Logosphere; 2019. P. 688–690. EDN: BUAHUQ

[22] Vereckei A, Duray G, Szénási G, et al. New algorithm using only lead AVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm. 2008;5(1):89–98. doi: 10.1016/j.hrthm.2007.09.020

[23] Vereckei A., Duray G., Szénási G., et al. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia // Heart Rhythm. 2008. Vol. 5, N 1. P. 89–98. doi: 10.1016/j.hrthm.2007.09.020

[24] Vereckei A, Duray G, Szénási G, et al. New algorithm using only lead AVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm. 2008;5(1):89–98. doi: 10.1016/j.hrthm.2007.09.020

[25] Lobo R, Jaffe AS, Cahill C, et al. Significance of high-sensitivity troponin t after elective external direct current cardioversion for atrial fibrillation or atrial flutter. Am J Cardiol. 2018;121(2):188–192. doi: 10.1016/j.amjcard.2017.10.009

[26] 9. Lobo R., Jaffe A.S., Cahill C., et al. Significance of high-sensitivity troponin T after elective external direct current cardioversion for atrial fibrillation or atrial flutter // Am J Cardiol. 2018. Vol. 121, N 2. P. 188–192. doi: 10.1016/j.amjcard.2017.10.009

[27] Lobo R, Jaffe AS, Cahill C, et al. Significance of high-sensitivity troponin t after elective external direct current cardioversion for atrial fibrillation or atrial flutter. Am J Cardiol. 2018;121(2):188–192. doi: 10.1016/j.amjcard.2017.10.009

[28] Stevenson WG, Friedman PL, Sager PT, et al. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol. 1997;29(6):1180–1189. doi: 10.1016/s0735-1097(97)00065-x

[29] Stevenson W.G., Friedman P.L., Sager P.T., et al. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping // J Am Coll Cardiol. 1997. Vol. 29. N 6. P.1180–1189. doi: 10.1016/s0735-1097(97)00065-x

[30] Stevenson WG, Friedman PL, Sager PT, et al. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol. 1997;29(6):1180–1189. doi: 10.1016/s0735-1097(97)00065-x

[31] Turkina AG, Nemchenko IS, Tsyba NN, et al. Clinical guidelines for the diagnosis and treatment of myeloproliferative diseases associated with eosinophilia. 2018. 30 р. (In Russ.) EDN RTBSCM

[32] Туркина А.Г., Немченко И.С., Цыба Н.Н., и др. Клинические рекомендации по диагностике и лечению миелопролиферативных заболеваний, протекающих с эозинофилией. 2018. 30 c. EDN: RTBSCM

[33] Turkina AG, Nemchenko IS, Tsyba NN, et al. Clinical guidelines for the diagnosis and treatment of myeloproliferative diseases associated with eosinophilia. 2018. 30 р. (In Russ.) EDN RTBSCM

[34] Butt NM, Lambert J, Ali S, et al. British committee for standards in haematology. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176(4):553–572. doi: 10.1111/bjh.14488

[35] Butt N.M., Lambert J., Ali S., et al. British committee for standards in haematology. Guideline for the investigation and management of eosinophilia // Br J Haematol. 2017. Vol. 176. N 4. P. 553–572. doi: 10.1111/bjh.14488

[36] Butt NM, Lambert J, Ali S, et al. British committee for standards in haematology. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176(4):553–572. doi: 10.1111/bjh.14488

[37] Groh M, Rohmer J, Etienne N et al. French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes. Orphanet J Rare Dis. 2023;18(1):100. doi: 10.1186/s13023-023-02696-4

[38] Groh M., Rohmer J., Etienne N., et al. French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes // Orphanet J Rare Dis. 2023. Vol. 18, N. 1, P. 100. doi: 10.1186/s13023-023-02696-4

[39] Groh M, Rohmer J, Etienne N et al. French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes. Orphanet J Rare Dis. 2023;18(1):100. doi: 10.1186/s13023-023-02696-4

[40] Medscape [Internet]. Samavedi VA, Sacher RA, Herrin VE, et al. Hypereosinophilic syndrome clinical presentation. [cited 2024 Sep. 18]. Available from: https://emedicine.medscape.com/article/202030-clinical

[41] Medscape [Электронный ресурс]. Samavedi V.A., Sacher R.A., Herrin V.E., et al. Hypereosinophilic syndrome clinical presentation. Режим доступа: https://emedicine.medscape.com/article/202030-clinical Дата обращения: 18.09.24.

[42] Medscape [Internet]. Samavedi VA, Sacher RA, Herrin VE, et al. Hypereosinophilic syndrome clinical presentation. [cited 2024 Sep. 18]. Available from: https://emedicine.medscape.com/article/202030-clinical

RIGHTS & PERMISSIONS

Eco-Vector